One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Quality standards for artificial intelligence-based studies and clinical trials
Filippo Crea
doi : 10.1093/eurheartj/ehad784
European Heart Journal, Volume 44, Issue 46, 7 December 2023, Pages 4815–4818
Actionable autophagy checkpoints in cardiovascular ageing
Mahmoud Abdellatif 1,2,3,4*, Léa Montégut2,3,5, and Guido Kroemer
Bioelectronics for neurocardiology: diagnosis and therapeutics
David J. Paterson 1*, and Kalyanam Shivkumar 2; for the Bioelectronics for Neurocardiology Consortium
The ESC Working Group on Coronary Pathophysiology and Microcirculation
Teresa Padro 1,2*, Edina Cenko 3, and Dimitris Tousoulis
Moving a STEP forward in the treatment of patients with obesity and heart failure with preserved ejection fraction
Giovanna Liuzzo 1,2* and Carlo Patrono
Five critical quality criteria for artificial intelligence-based prediction models
Florien S. van Royen 1, Folkert W. Asselbergs 2,3, Fernando Alfonso 4, Panos Vardas5, and Maarten van Smeden
Endpoint adjudication in cardiovascular clinical trials
Muhammad Shahzeb Khan 1*†, Muhammad Shariq Usman 2,3†, Harriette G. C. Van Spall4,5, Stephen J. Greene1,6, Omar Baqal7, Gary Michael Felker1,6, Deepak L. Bhatt8, James L. Januzzi9,10, and Javed Butler
Intra-pocket ultrasound-guided axillary vein puncture vs. cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial
Paul Charles 1*†, Geoffroy Ditac 1†, Mathieu Montoy1, Thibaut Thenard1, Pierre-Yves Courand 1,2, Pierre Lantelme 1,2, Brahim Harbaoui 1,2, and Samir Fareh
Different techniques of venous access for CIEDs: advantages and disadvantages
Michele Brignole 1* and Jean-Claude Deharo
Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study
Susheel Kodali1*, Rebecca T. Hahn1, Raj Makkar 2, Moody Makar2, Charles J. Davidson3, Jyothy J. Puthumana3, Firas Zahr 4, Scott Chadderdon4, Neil Fam5, Geraldine Ong5, Pradeep Yadav6, Vinod Thourani6, Mani A. Vannan6, William W. O’Neill7, Dee Dee Wang7, Didier Tchétché8, Nicolas Dumonteil8, Laurent Bonfils8, Laurent Lepage8, Robert Smith9, Paul A. Grayburn9,10, Rahul P. Sharma11, Christiane Haeffele
From TriValve to TRILUMINATE to TRISCEND: what have we learned?
Solomon W. Bienstock and Gregg W. Stone
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial
Jessica M. Scott 1,2 , Jasme Lee 1 , James E. Herndon3 , Meghan G. Michalski 1 , Catherine P. Lee 1 , Kelly A. O’Brien 1 , John P. Sasso4 , Anthony F. Yu 1,2 , Kylie A. Rowed 1 , Jacqueline F. Bromberg 1,2 , Tiffany A. Traina1,2 , Ayca Gucalp 1,2 , Rachel A. Sanford1 , Devika Gajria 1,2 , Shanu Modi 1,2 , Elisabeth A. Comen1,2 , Gabriella D’Andrea1,2 , Victoria S. Blinder 1,2 , Neil D. Eves4 , Jeffrey M. Peppercorn 5 , Chaya S. Moskowitz1 , Chau T. Dang1,2 , and Lee W. Jones
Best timing for exercise in breast cancer patients initiating chemotherapy: what is the answer?
Ana Abreu
Revascularization for left main coronary artery disease
Fernando Alfonso *, Alexander Marschall , and Fernando Rivero
Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies
Jonas Persson 1*, Torbj?rn Ivert 2,3, and Elmir Omerovic
Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement
?ukasz Kali?czuk 1*, Wiktor Skotarczak1, Lars Sondergaard2, and Gary S. Mintz
One of the open ductus dissected during pregnancy
Anne J. Koppelaar 1*, Alex J. Eggink2, and Johannes M. I. H. Gho
